Purified anti-mouse/human CD11b Antibody

Pricing & Availability
Clone
M1/70 (See other available formats)
Regulatory Status
RUO
Other Names
αM integrin, Mac-1, Mo1, CR3, Ly-40, C3biR, ITGAM
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
1-M1slash70_Purified_042706
C57BL/6 mouse bone marrow cells were stained with purified CD11b (clone M1/70) (filled histogram) or rat IgG2b, κ isotype control (open histogram), followed by anti-rat IgG FITC (gated on total cells).
  • 1-M1slash70_Purified_042706
    C57BL/6 mouse bone marrow cells were stained with purified CD11b (clone M1/70) (filled histogram) or rat IgG2b, κ isotype control (open histogram), followed by anti-rat IgG FITC (gated on total cells).
  • 2-M170_Pure_CD11b_Antibody_IHC_102418
    Fresh, frozen mouse spleen was stained with purified CD11b clone M1/70 conjugated and detected with a Cy5 CODEX™ oligonucleotide duplex (red). Samples were counterstained with TCR FITC (green). Data generated at Akoya Biosciences, Inc. using the CODEX™ technology.
Compare all formats
Cat # Size Price Quantity Check Availability Save
101201 50 µg 24€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
101202 500 µg 92€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD11b is a 170 kD glycoprotein also known as αM integrin, Mac-1 α subunit, Mol, CR3, and Ly-40. CD11b is a member of the integrin family, primarily expressed on granulocytes, monocytes/macrophages, dendritic cells, NK cells, and subsets of T and B cells. CD11b non-covalently associates with CD18 (β2 integrin) to form Mac-1. Mac-1 plays an important role in cell-cell interaction by binding its ligands ICAM-1 (CD54), ICAM-2 (CD102), ICAM-4 (CD242), iC3b, and fibrinogen.

Product Details
Technical data sheet

Product Details

Verified Reactivity
Mouse, Human, Cynomolgus, Rhesus
Reported Reactivity
Chimpanzee, Baboon, Rabbit
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
C57BL/10 splenocytes
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C.
Application

FC - Quality tested
IHC-F, CyTOF® - Verified
IP, ICC - Reported in the literature, not verified in house

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µL volume. It is recommended that the reagent be titrated for optimal performance for each application.

Application Notes

Clone M1/70 has been verified for immunocytochemistry (ICC) and frozen immunohistochemistry (IHC-F).

Additional reported applications (for relevant formats of this clone) include: immunoprecipitation1,4, in vitro blocking3,9,12, depletion2,8, immunofluorescence microscopy6,7,10, immunohistochemistry of acetone-fixed frozen sections5,11-13, and spatial biology (IBEX)35,36. For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) (Cat. No. 101248).

Application References

(PubMed link indicates BioLegend citation)
  1. Springer T, et al. 1978. Eur. J. Immunol. 8:539. (IP)
  2. Ault K and Springer T. 1981. J. Immunol. 126:359. (Deplete)
  3. Springer TA, et al. 1982. Immunol. Rev. 68:171. (Block)
  4. Ho MK and Springer TA. 1983. J. Biol. Chem. 258:2766. (IP)
  5. Flotte TJ, et al. 1983. Am. J. Pathol. 111:112. (IHC)
  6. Noel GJ, et al. 1990. J. Clin. Invest. 85:208. (IF)
  7. Allen LA and Aderem A. 1996. J. Exp. Med. 184:627 (IF)
  8. D'Amico A and Wu L. 2003. J. Exp. Med. 198:293. (Deplete)
  9. Brickson SJ, et al. 2003. Appl Physiol. 95:969. (Block)
  10. Clatworthy MR and Smith KG. 2004. J. Exp. Med. 199:717. (IF)
  11. Hata H, et al. 2004. J. Clin. Invest. 114:582. (IHC)
  12. Zhang Y, et al. 2002. J. Immunol. 168:3088. (IHC)
  13. Iwasaki A and Kelsall BL. 2001. J. Immunol. 166:4884 (IHC, FC)
  14. Tailleux L. 2003. J. Exp. Med. 197:121. (Block, FC)
  15. Olver S, et al. 2006. Cancer Research 66:571. (FC)
  16. Tan SL, et al. 2006. J. Immunol. 176:2872. (FC) PubMed
  17. Ponomarev ED, et al. 2006. J. Immunol. 176:1402. (FC)
  18. Dzhagalov I, et al. 2007. Blood 109:1620. (FC)
  19. Fazilleau N, et al. 2007. Nature Immunol. 8:753.
  20. Rasmussen JW, et al. 2006. Infect. Immun.74:6590. PubMed
  21. Napimoga MH, et al. 2008. J. Immunol. 180:609. PubMed
  22. Elqaraz-Carmon V, et al. 2008. J. Lipid. Res. 49:1894. PubMed
  23. Kim DD, et al. 2008. Blood 112:1109. PubMed
  24. Guo Y, et al. 2008. Blood 112:480. PubMed
  25. Norian LA, et al. 2009. Cancer Res. 69:3086. (FC) PubMed
  26. Baumgartner CK, et al. 2010. J. Immunol. 184:573. PubMed
  27. Charles N, et al. 2010. Nat. Med. 16:701. (FC) PubMed
  28. Whiteland J, et al. 1995. J. Histochem. Cytochem. 43:313. (IHC)
  29. Weber GF, et al. 2014. J Exp Med. 211:1243. PubMed
  30. Ashok A, et al. 2015. Toxicol Sci. 143:64. PubMed
  31. Price PJ, et al. 2015. J Immunol. 194:1164. PubMed
  32. Doni A, et al. 2015. J Exp Med. 212:905. PubMed
  33. Ferreira R, et al. 2016. J Infect Dis. 213: 669 - 673. PubMed
  34. Peterson VM, et al. 2017. Nat. Biotechnol. 35:936. (PG)
  35. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  36. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Hutton C, et al. 2021. Cancer Cell. 39:1227. PubMed
  2. Kobayashi A, et al. 2021. Front Immunol. 12:650856. PubMed
  3. Paterson MJ, et al. 2020. PLoS Pathog. 16:e1008733. PubMed
  4. Peterson EJ, et al. 2019. Mol Syst Biol. 15:e8584. PubMed
  5. Axelrod HD, et al. 2019. Mol Cancer Res. 17:356. PubMed
  6. Tong CF, et al. 2018. Am J Physiol Cell Physiol. 315:C409. PubMed
  7. Arnold IC, et al. 2019. PLoS Pathog. 15:e1007866. PubMed
  8. Wolf Y, et al. 2017. J Exp Med. 214:905. PubMed
  9. Taki M, et al. 2018. Nat Commun. 1.545138889. PubMed
  10. Vinaik R, et al. 2019. Am J Physiol Endocrinol Metab. 317:E751. PubMed
  11. Yonemitsu K, et al. 2022. Sci Rep. 12:12007. PubMed
  12. Pilling D, et al. 2022. Respir Res. 23:215. PubMed
  13. Bajaña S, et al. 2021. Front Immunol. 11:577718. PubMed
  14. Zhao J, et al. 2021. JCI Insight. 6:. PubMed
  15. Larson-Casey JL, et al. 2021. FASEB J. 35:e21675. PubMed
  16. Khan KA, et al. 2020. NPJ Breast Cancer. 6:29. PubMed
  17. Kim D, et al. 2008. Blood. 112:1109. PubMed
  18. Mazor R, et al. 2018. Proc Natl Acad Sci U S A. 115:E733. PubMed
  19. Chung MI, et al. 2018. Am J Respir Cell Mol Biol. 59:706. PubMed
  20. Burrello C, et al. 2018. Front Med (Lausanne). 5:21. PubMed
  21. Chartrand K, et al. 2018. Front Immunol. 1.642361111. PubMed
  22. Shirakawa K, et al. 2017. PLoS One. 12:e0186303. PubMed
  23. Zhou LJ et al. 2019. Cell Rep. 27(13):3844-3859 . PubMed
  24. Reglero-Real N, et al. 2021. Immunity. :. PubMed
  25. Weidner H, et al. 2020. JCI Insight. 5:00. PubMed
  26. Prado C, et al. 2021. J Neuroinflammation. 18:292. PubMed
  27. Leyva-Castillo JM, et al. 2020. Clin Immunol. 218:108511. PubMed
  28. Bachran C, et al. 2017. Sci Rep.. 10.1038/s41598-017-17948-0. PubMed
  29. Wagner J et al. 2019. Cell. 177(5):1330-1345 . PubMed
  30. Peng J, et al. 2019. Mol Brain. 12:71. PubMed
  31. Ajona D, et al. 2017. Cancer Discov. 0.773611111. PubMed
  32. Goel S, et al. 2017. Nature. 548:471. PubMed
  33. Tang B, et al. 2019. Oncolytic Virother. 8:03. PubMed
  34. Wang W, et al. 2018. Cancer Cell. 34:757. PubMed
  35. Arnold IC, et al. 2018. J Exp Med. 215:2055. PubMed
  36. Dertschnig S, et al. 2020. J Clin Invest. 130:1896. PubMed
  37. Dienz O, et al. 2020. J Immunol. 204:1521. PubMed
  38. Nguyen N, et al. 2022. iScience. 25:103679. PubMed
  39. Karhadkar TR, et al. 2021. J Pharmacol Exp Ther. 376:106. PubMed
  40. Rogic A, et al. 2021. Nat Commun. 12:6889. PubMed
  41. Chen L, et al. 2019. Nat Commun. 3.553472222. PubMed
  42. Cao Q, et al. 2018. Am J Physiol Renal Physiol. 314:F561. PubMed
  43. Lechner AJ et al. 2017. Cell stem cell. 21(1):120-134 . PubMed
  44. Bredehöft J, et al. 2022. J Inflamm Res. 15:509. PubMed
  45. Tian D, et al. 2020. FASEB J. 34:3367. PubMed
  46. Stefanescu C, et al. 2021. Front Oncol. 11:765151. PubMed
  47. Dave K et al. 2017. eLife. 6 pii: e23382. PubMed
  48. Arimura K, et al. 2017. Mucosal Immunol. 1.08125. PubMed
  49. Liu T, et al. 2020. Sci Adv. 6:eaay1497. PubMed
  50. Peng J, et al. 2016. Nat Commun. 7:12029. PubMed
  51. Lee JH, et al. 2022. iScience. 25:104166. PubMed
  52. Delgobo M, et al. 2021. Front Immunol. 12:584538. PubMed
  53. Haney MS, et al. 2018. Nat Genet. 50:1716. PubMed
  54. McLeod RL, et al. 2018. Oncotarget. 9:34459. PubMed
  55. Rissiek B, et al. 2017. Sci Rep. . 10.1038/s41598-017-16613-w. PubMed
  56. Tal MC, et al. 2020. MBio. 11:00. PubMed
  57. Ashok A, et al. 2015. Toxicol Sci. 143:64. PubMed
  58. Gui J, et al. 2020. Nat Cancer. 1:603. PubMed
  59. Si Y, et al. 2020. Sci Adv. 6:eaaw7713. PubMed
  60. O'Dea KP, et al. 2020. J Extracell Vesicles. 9:1706708. PubMed
  61. Matsuhira T, et al. 2021. Biochem Biophys Rep. 28:101118. PubMed
  62. Suzuki Y, et al. 2021. FEBS Open Bio. 11:2619. PubMed
  63. Yan J, et al. 2020. Cancer Immunol Res. 8:356. PubMed
  64. Gomi M, et al. 2021. Mol Ther. 29:225. PubMed
  65. Chen L, et al. 2020. Front Immunol. 11:584458. PubMed
  66. Nolin JD, et al. 2017. JCI Insight. 2:e94929. PubMed
  67. Chen S, et al. 2018. Immunohorizons. 0.345138889. PubMed
  68. Yang C, et al. 2019. MBio. 10:e00595-19. PubMed
  69. Silvestre-Roig C, et al. 2019. Nature. 569:236. PubMed
  70. Khan KA, et al. 2020. NPJ Breast Cancer. 6:29. PubMed
  71. Guiducci E, et al. 2018. Front Immunol. 1.467361111. PubMed
  72. Guo Y, et al. 2008. Blood. 112:480. PubMed
  73. He LD, et al. 2021. EMBO Rep. 22:e52196. PubMed
  74. Sun Y, et al. 2022. Nat Commun. 13:3916. PubMed
  75. Seelige R, et al. 2018. Sci Rep. 8:13670. PubMed
  76. Zhao L, et al. 2018. Nat Med. 24:1536. PubMed
  77. Manni M, et al. 2018. Nat Immunol. 1.074305556. PubMed
  78. Stacey MA, et al. 2017. J Clin Invest. 127:1463. PubMed
  79. Karhadkar TR, et al. 2021. PLoS One. 16:e0245924. PubMed
  80. Lai JF, et al. 2020. J Allergy Clin Immunol. 146:1406. PubMed
  81. Vukman KV, et al. 2020. J Extracell Vesicles. 10:e12023. PubMed
  82. Jiang L, et al. 2022. Front Immunol. 12:730438. PubMed
  83. Sato Y, et al. 2021. BMC Cancer. 21:1222. PubMed
  84. Liu H, et al. 2020. J Immunol. 205:1207. PubMed
  85. Muraleedharan A, et al. 2021. Glia. 69:697. PubMed
  86. Bednarczyk M, et al. 2021. Int J Mol Sci. 22:. PubMed
  87. Shokirova H, et al. 2021. Sci Rep. 11:8647. PubMed
  88. Brown IK, et al. 2021. PLoS Pathog. 17:e1009602. PubMed
  89. Gartlan KH, et al. 2019. Blood Adv. 2.110416667. PubMed
  90. Abboud G, et al. 2018. Front Immunol. 9:1973. PubMed
  91. Napimoga M, et al. 2008. J Immunol. 180:609. PubMed
  92. Francis M, et al. 2017. Toxicol Sci. 155(1):182-195. PubMed
  93. Hakamivala A, et al. 2020. Bioact Mater. 5:142. PubMed
  94. Wei S, et al. 2019. Virulence. 0.588888889. PubMed
  95. Kapellos TS, et al. 2017. Mediators Inflamm. 2017:4315412. PubMed
  96. Umemoto T, et al. 2017. EMBO J. 36:2390. PubMed
  97. Kim SJ, et al. 2017. Nat Immunol. 18:1016. PubMed
  98. Tsubaki T, et al. 2018. Oncotarget. 9:11209. PubMed
  99. Wicki S, et al. 2018. Int J Mol Sci. 1.266666667. PubMed
  100. Hoves S, et al. 2018. J Exp Med. 215:859. PubMed
  101. Zhong X, et al. 2020. Proc Natl Acad Sci U S A. 8563:117. PubMed
  102. Zareie P, et al. 2017. J Neuroinflammation. 0.630555556. PubMed
  103. Krueger A, et al. 2022. Front Microbiol. 12:789042. PubMed
  104. Johnson SA, et al. 2021. Eur J Immunol. 51:3228. PubMed
  105. Manabe T, et al. 2021. J Neurochem. 159:525. PubMed
  106. Schuler CF, et al. 2020. Allergy. 75:2279. PubMed
  107. Lim CS, et al. 2020. Front Immunol. 11:1186. PubMed
  108. Yoon S, et al. 2020. Antioxidants (Basel). 10:. PubMed
  109. Tao H, et al. 2021. Front Immunol. 12:623280. PubMed
  110. You X, et al. 2022. Front Genet. 12:790990. PubMed
  111. Lee JY, et al. 2018. Front Immunol. 0.678472222. PubMed
  112. Davies CL, et al. 2019. Front Immunol. 10:1048. PubMed
  113. Paharik AE, et al. 2017. Cell Host Microbe. 22:746. PubMed
  114. Nascimento DC, et al. 2017. Nat Commun. 8:14919. PubMed
  115. Shin J, et al. 2018. Diabetes. 67:1068. PubMed
  116. Majer O, et al. 2019. Nature. 575:366. PubMed
  117. Coden ME, et al. 2020. J Immunol. 204:438. PubMed
  118. Chen HW, et al. 2021. Biomedicines. 9:. PubMed
  119. Daley D, et al. 2017. Nat Med. 23:556. PubMed
  120. Hsieh JY, et al. 2019. APL Bioeng. 3:016103. PubMed
  121. Nagatake T, et al. 2018. Int Immunol. 30:471. PubMed
  122. Karhadkar TR, et al. 2020. bioRxiv. . PubMed
  123. Huang S, et al. 2020. Cell Rep. 33:108394. PubMed
  124. Yi MH, et al. 2020. Brain Behav Immun. 92:78. PubMed
  125. Meyer-Lindemann U, et al. 2022. Front Immunol. 13:898690. PubMed
  126. Tsukui H, et al. 2020. BMC Cancer. 20:411. PubMed
  127. Li J, et al. 2021. Front Immunol. 12:710406. PubMed
  128. Madsen D, et al. 2017. Cell Rep.. 10.1016/j.celrep.2017.12.011. PubMed
  129. Fino KK, et al. 2017. Sci Rep. 5.334722222. PubMed
  130. Yoon BH, et al. 2018. Mol Cells. 41:953. PubMed
  131. Hoffmann FM, et al. 2018. Front Immunol. 9:1046. PubMed
  132. Baumgartner C, et al. 2010. J Immunol. 184:573. PubMed
  133. Nguyen CH, et al. 2020. Biomedicines. 8:. PubMed
  134. Seo SU, et al. 2021. Front Immunol. 12:697162. PubMed
  135. Speir M, et al. 2020. Nat Immunol. 21:54. PubMed
  136. Kikuchi A, et al. 2020. Am J Pathol. 190:2080. PubMed
  137. Freeman SA, et al. 2020. Science. 367:301. PubMed
  138. Kim D, et al. 2019. Immune Netw. 19:e32. PubMed
  139. Kawabe T, et al. 2017. Sci Immunol. 2:eaam9315. PubMed
  140. Galbas T, et al. 2017. J Immunol. 198(2):852-861. PubMed
  141. Ding L, et al. 2022. Nanoscale. . PubMed
  142. Scortegagna M, et al. 2020. Nat Commun. 11:99. PubMed
  143. Vahsen BF, et al. 2022. Sci Rep. 12:12606. PubMed
  144. Brownlie D, et al. 2021. J Immunother Cancer. 9:. PubMed
  145. Akiel M, et al. 2017. Cancer Res. 77:4014. PubMed
  146. Wang Y, et al. 2019. Biomed Res Int. 2019:5756189. PubMed
  147. Roussey JA, et al. 2017. J Immunol. 199:3535. PubMed
  148. Elgazar-Carmon V, et al. 2008. J Lipid Res. 49:1849. PubMed
  149. Düking T, et al. 2022. Sci Adv. 8:eabo7639. PubMed
  150. Wu W, et al. 2020. Brain Behav Immun. 89:245. PubMed
  151. Qiu Z, et al. 2022. Cancer Discov. 12:502. PubMed
  152. Link CWM, et al. 2020. Front Immunol. 11:596772. PubMed
  153. Lin Z, et al. 2021. Stem Cells. 39:240. PubMed
  154. Takeuchi Y, et al. 2021. Sci Rep. 11:18679. PubMed
  155. Feng L, et al. 2019. Glia. 67:1434. PubMed
  156. Wagner AK, et al. 2017. Nat Commun. 8:15627. PubMed
  157. Yamasaki T, et al. 2018. J Virol. 92:e01458. PubMed
  158. Mohrin M, et al. 2021. Aging Cell. 20:e13313. PubMed
  159. Cané S, et al. 2021. J Immunother Cancer. 9:. PubMed
  160. Udumula MP, et al. 2021. Mol Metab. 53:101272. PubMed
  161. Lee YJ, et al. 2018. Front Microbiol. 9:83. PubMed
  162. Nicolas-Boluda A, et al. 2021. eLife. 10:00. PubMed
  163. Stotesbury C, et al. 2020. Aging Cell. 19:e13170. PubMed
  164. Wen J, et al. 2021. PLoS Pathog. 17:e1009738. PubMed
  165. Murenu E, et al. 2021. Mol Ther Methods Clin Dev. 20:587. PubMed
  166. Murenu E, et al. 2021. Int J Mol Sci. 22:. PubMed
  167. Olver S, et al. 2005. Cancer Res. 66:571. PubMed
  168. Cole C, et al. 2018. Nucleic Acids Res. 46:e62. PubMed
  169. Andrews AR, et al. 2019. Cancer Cell Int. 0.955555556. PubMed
  170. Diao J, et al. 2018. J Immunol. 201:1306. PubMed
  171. Pushalkar S, et al. 2018. Cancer Discov. 0.613194444. PubMed
  172. Ortiz A, et al. 2019. Cancer Cell. 35:33:00. PubMed
  173. Winter C, et al. 2018. Cell Metab. 28:175. PubMed
  174. Karuppuchamy T, et al. 2020. Inflamm Bowel Dis. 216:26. PubMed
  175. Aikawa S, et al. 2020. Cell Death Differ. 1489:27. PubMed
  176. Heib T, et al. 2021. Cell Reports. 35(6):109102. PubMed
  177. Chevrier S, et al. 2021. Cell Reports Medicine. 2(1):100166. PubMed
  178. Rossnagl S, et al. 2016. PLoS Biol. 14: 1002562. PubMed
  179. Sun Y, et al. 2015. Proc Natl Acad Sci U S A. 112: 10401-10406. PubMed
  180. Zheng C, et al. 2021. J Extracell Vesicles. 10:e12109. PubMed
  181. Song M, et al. 2020. Nat Commun. 11:6298. PubMed
  182. Dubik M, et al. 2021. Front Neurosci. 15:682451. PubMed
  183. An Y et al. 2018. Cell reports. 25(3):702-714 . PubMed
  184. Chevrier S, et al. 2018. Cell Syst. 0.675. PubMed
  185. Kikuchi K, et al. 2018. J Immunol. 201:635. PubMed
  186. Larson–Casey JL, et al. 2019. J Clin Invest. 129:4962. PubMed
  187. Zhang J, et al. 2019. Onco Targets Ther. 12:4985. PubMed
  188. Hsieh YL, et al. 2019. Cell Reports. 29(8):2134-2143.e7. PubMed
  189. Kästele V, et al. 2021. Mucosal Immunol. 14:717. PubMed
  190. Flores I, et al. 2021. Hum Mol Genet. Online ahead of print. PubMed
  191. Li Y, et al. 2021. Life Sci Alliance. 4:. PubMed
  192. Prabakaran T, et al. 2021. EBioMedicine. 66:103314. PubMed
  193. Kang SH, et al. 2018. Oncoimmunology. 8:e1515057. PubMed
  194. Shao Y, et al. 2017. Onco Targets Ther. 10:2675. PubMed
  195. Fritz Y, et al. 2017. J Invest Dermatol. 137:696. PubMed
  196. Ito Y, et al. 2018. J Exp Med. 215:2617. PubMed
  197. Regan–Komito D, et al. 2017. Front Immunol. 1.459027778. PubMed
  198. He X, et al. 2017. Cancer Biol Ther. 0.815277778. PubMed
  199. Torika N, et al. 2018. CNS Neurosci Ther. 24:231. PubMed
  200. Zhou N et al. 2018. Protein & cell. 10(2):87-103 . PubMed
  201. Li X, et al. 2020. J Clin Invest. 130:4182. PubMed
RRID
AB_312784 (BioLegend Cat. No. 101201)
AB_312785 (BioLegend Cat. No. 101202)

Antigen Details

Structure
Integrin family, associates with integrin β2 (CD18), 170 kD
Distribution

Granulocytes, monocytes/macrophages, dendritic cells, NK cells, subsets of T and B cells

Function
Adhesion, chemotaxis
Ligand/Receptor
ICAM-1 (CD54), ICAM-2 (CD102), ICAM-4 (CD242), iC3b, fibrinogen
Cell Type
B cells, Dendritic cells, Granulocytes, Macrophages, Monocytes, Neutrophils, NK cells, T cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Costimulatory Molecules, Immunology, Innate Immunity, Neuroscience, Neuroscience Cell Markers
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Springer TA. 1994. Cell 76:301.
3. Coxon A, et al. 1996. Immunity 5:653.

Gene ID
16409 View all products for this Gene ID 3684 View all products for this Gene ID
UniProt
View information about CD11b on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD11b Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse/human CD11b M1/70 FC
Biotin anti-mouse/human CD11b M1/70 FC
FITC anti-mouse/human CD11b M1/70 FC
PE anti-mouse/human CD11b M1/70 FC, IHC
PE/Cyanine5 anti-mouse/human CD11b M1/70 FC
Purified anti-mouse/human CD11b M1/70 FC, CyTOF®, IP, IHC-F, ICC
PE/Cyanine7 anti-mouse/human CD11b M1/70 FC
Alexa Fluor® 488 anti-mouse/human CD11b M1/70 FC, IHC-F, 3D IHC, SB
Alexa Fluor® 647 anti-mouse/human CD11b M1/70 FC, 3D IHC
Alexa Fluor® 700 anti-mouse/human CD11b M1/70 FC
Pacific Blue™ anti-mouse/human CD11b M1/70 FC
APC/Cyanine7 anti-mouse/human CD11b M1/70 FC
PerCP/Cyanine5.5 anti-mouse/human CD11b M1/70 FC
PerCP anti-mouse/human CD11b M1/70 FC
Brilliant Violet 421™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 570™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 605™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 650™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 711™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 785™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 510™ anti-mouse/human CD11b M1/70 FC, ICC
Ultra-LEAF™ Purified anti-mouse/human CD11b M1/70 FC, CyTOF®, IP, Block, Depletion, IHC-F, ICC
Purified anti-mouse/human CD11b (Maxpar® Ready) M1/70 FC, CyTOF®
Alexa Fluor® 594 anti-mouse/human CD11b M1/70 IHC-F, FC
PE/Dazzle™ 594 anti-mouse/human CD11b M1/70 FC
APC/Fire™ 750 anti-mouse/human CD11b M1/70 FC
TotalSeq™-A0014 anti-mouse/human CD11b M1/70 PG
Brilliant Violet 750™ anti-mouse/human CD11b M1/70 FC
TotalSeq™-B0014 anti-mouse/human CD11b M1/70 PG
TotalSeq™-C0014 anti-mouse/human CD11b M1/70 PG
Spark NIR™ 685 anti-mouse/human CD11b M1/70 FC
PE/Fire™ 640 anti-mouse/human CD11b M1/70 FC
Spark YG™ 593 anti-mouse/human CD11b M1/70 FC
Spark YG™ 570 anti-mouse/human CD11b M1/70 IHC-F
PE/Fire™ 810 anti-mouse/human CD11b M1/70 FC
APC/Fire™ 810 anti-mouse/human CD11b Antibody M1/70 FC
Spark Blue™ 550 anti-mouse/human CD11b M1/70 FC
Spark UV™ 387 anti-mouse/human CD11b M1/70 FC
Go To Top Version: 4    Revision Date: 12.13.2019

For research use only. Not for diagnostic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.

 

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/ordering#license). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.

 

BioLegend Inc., 8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

  • APC anti-mouse/human CD11b

  • Biotin anti-mouse/human CD11b

  • FITC anti-mouse/human CD11b

  • PE anti-mouse/human CD11b

  • PE/Cyanine5 anti-mouse/human CD11b

  • Purified anti-mouse/human CD11b

  • PE/Cyanine7 anti-mouse/human CD11b

  • Alexa Fluor® 488 anti-mouse/human CD11b

  • Alexa Fluor® 647 anti-mouse/human CD11b

  • Alexa Fluor® 700 anti-mouse/human CD11b

  • Pacific Blue™ anti-mouse/human CD11b

  • APC/Cyanine7 anti-mouse/human CD11b

  • PerCP/Cyanine5.5 anti-mouse/human CD11b

  • PerCP anti-mouse/human CD11b

  • Brilliant Violet 421™ anti-mouse/human CD11b

  • Brilliant Violet 570™ anti-mouse/human CD11b

  • Brilliant Violet 605™ anti-mouse/human CD11b

  • Brilliant Violet 650™ anti-mouse/human CD11b

  • Brilliant Violet 711™ anti-mouse/human CD11b

  • Brilliant Violet 785™ anti-mouse/human CD11b

  • Brilliant Violet 510™ anti-mouse/human CD11b

  • Ultra-LEAF™ Purified anti-mouse/human CD11b

  • Purified anti-mouse/human CD11b (Maxpar® Ready)

  • Alexa Fluor® 594 anti-mouse/human CD11b

  • PE/Dazzle™ 594 anti-mouse/human CD11b

  • APC/Fire™ 750 anti-mouse/human CD11b

  • TotalSeq™-A0014 anti-mouse/human CD11b

  • Brilliant Violet 750™ anti-mouse/human CD11b

  • TotalSeq™-B0014 anti-mouse/human CD11b

  • TotalSeq™-C0014 anti-mouse/human CD11b

  • Spark NIR™ 685 anti-mouse/human CD11b

  • PE/Fire™ 640 anti-mouse/human CD11b

  • Spark YG™ 593 anti-mouse/human CD11b

  • Spark YG™ 570 anti-mouse/human CD11b

  • PE/Fire™ 810 anti-mouse/human CD11b

  • APC/Fire™ 810 anti-mouse/human CD11b Antibody

  • Spark Blue™ 550 anti-mouse/human CD11b

  • Spark UV™ 387 anti-mouse/human CD11b

ProductsHere

Login / Register
Remember me
Forgot your password? Reset password?
Create an Account